Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

Tomasz Guszczyn; Monika Kulesza; Aleksandra Kicman; Joanna Motyka; Sławomir Ławicki

doi:10.12659/MSM.941523

18 December 2023: Clinical Research

Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

Tomasz Guszczyn ^1ABDEF* , Monika Kulesza ^2BCDEF , Aleksandra Kicman ^3CF , Joanna Motyka ^2CF , Sławomir Ławicki ^2AEG

DOI: 10.12659/MSM.941523

Med Sci Monit 2023; 29:e941523

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Table 4 The impact of limb immobilization prior to PRP injection on treatment outcomes: the results after PRP injection assessed on the pain scale (VAS) and knee joint function scales (Tegner, Lysholm, and KOOS), was evaluated using the linear regression model after stepwise elimination.

	Treatment before PRP injection	Linear regression model after stepwise elimination
	Treatment before PRP injection	Non-standardized factor	Standardized factor	p*	Adjusted R2
VAS scale after injection PRP	Immobilization	−1.070	−0.303		0.315
Tegner scale after injection PRP	Immobilization	−0.350	−0.089		0.883
Lysholm scale after injection PRP	Immobilization	−1.594	−0.140		0.307
KOOS scale after injection PRP	Immobilization	−3.348	−0.228		0.445

Back to the Article

Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

Your Privacy